- •Marked myocardial hypoattenuation noted on contrast-enhanced CT in a patient with cardiac sarcoidosis.
- •Myocardial hypoattenuation correlates with a perfusion defect and LGE on CMR, increased FDG activity on PET and a perfusion defect on SPECT.
- •Contrast-enhanced CT may provide information regarding myocardial tissue characterization.
- •CMR and FDG-PET demonstrate clinical utility for evaluation of cardiac sarcoidosis and monitoring response to therapy.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Delayed contrast-enhanced computed tomography in patients with known or suspected cardiac sarcoidosis: a feasibility study.Eur Radiol. 2017; 27: 4054-4063
- Active cardiac sarcoidosis on standard chest computed tomography.Eur Heart J Cardiovasc Imaging. 2018; 19: 1025
- Assessment of myocardial infarctions using multidetector-row computed tomography.J Comput Assist Tomogr. 2004; 28: 286-292